Signatur Biosciences (YC S22) Information

Signatur Biosciences makes precision diagnostics more accessible, starting by bringing breast cancer testing within reach for women around the world. Traditional tests used to guide therapy are slow and expensive due to their reliance on complex, centralized facilities. Our tests are designed to seamlessly integrate with standard instruments and workflows already in place in every clinical lab. Our assays empower local labs to deliver results in hours instead of weeks and at a fraction of the cost, significantly increasing accessibility, including for underserved patient populations. Signatur Biosciences is a spinout backed by YCombinator, founded by bioengineers from Imperial College and Oxford University.